Christopher Thomas Evans is listed as a director on 2 SEC Form D filings by 2 issuers between Oct 2010 and Sep 2014: Lab21 Ltd (Cambridge, United Kingdom (as filed: X0) — biotechnology — 2010; $838K reported sold to 11 investors) and Plethora Solutions Holdings plc (Chalgrove, Oxfordshire, United Kingdom (as filed: X0) — pharmaceuticals — 2014).
What this means 2 separate companies raised money with this person listed as director, over about 4 years. Across those companies the filings report $838K sold in total.
Listed alongside Ann Gail Hayes (1 shared filing), Anthony Atkinson (1 shared filing), Berwyn Clarke (1 shared filing), Bradley Richard Hoy (1 shared filing), David Ellam (1 shared filing) and 19 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Christopher. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 2 public filings for Christopher Thomas Evans and found 3 differences: No amendment in the last 12 months on an offering that may still be open; Christopher Thomas Evans is written 2 different ways on the filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.